According to in-store data from Grips Intelligence covering January to April 2026 across Menards and Lowe's, Oxygenics demonstrates a highly concentrated retail footprint, with Menards accounting for 95.5% of total revenue share compared to just 4.5% at Lowe's. The brand's average product price during this period stood at $47.94, though pricing showed a downward trend with a 9.2% overall decrease observed across the tracked months. Revenue also experienced a notable decline, dropping 8.0% over the measured period, including a sharp 17.7% month-over-month fall in the most recent month. This combination of declining prices and contracting revenue suggests Oxygenics may be facing increased competitive pressure or shifting consumer demand within its core retail channels. Analysts and retailers monitoring the brand should watch whether this downward trajectory stabilizes in the coming months.
OVER TIME
Over the last three months, revenue on tracked retailers has declined by 8% from Feb to Apr.
OVER TIME
Over the last three months, average selling price on tracked retailers has decreased by 9% from Feb to Apr.
REVENUE SHARE
Revenue distribution across product categories for Oxygenics on Lowe's.
REVENUE SHARE
Revenue distribution across tracked retailers for Oxygenics.
BY REVENUE
$34.98
Price
$5K
Revenue
$39.98
Price
$2.4K
Revenue
$78.98
Price
$2.13K
Revenue
$69.98
Price
$1.96K
Revenue
$42.40
Price
$1.91K
Revenue